alogliptin 6.25 MG (as alogliptin benzoate 8.5 MG) Oral Tablet
- RxCUI
- 1368018
- RxNorm name
- alogliptin 6.25 MG (as alogliptin benzoate 8.5 MG) Oral Tablet
- Display name
- alogliptin 6.25 MG (as alogliptin benzoate 8.5 MG) Oral Tablet
- Full name
- alogliptin 6.25 MG (as alogliptin benzoate 8.5 MG) Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:12
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Alogliptin | ALOGLIPTIN | Padagis Israel Pharmaceuticals Ltd | b25f155a-1259-47c2-aa3b-7c1356e4c7f6 | 2025-04-11 | Warnings, Adverse reactions | 1368018 |
| Nesina | ALOGLIPTIN | Takeda Pharmaceuticals America, Inc. | a3768c7e-aa4c-44d3-bc53-43bb7346c0b0 | 2025-02-28 | Warnings, Adverse reactions | 1368018 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a3768c7e-aa4c-44d3-bc53-43bb7346c0b0 | alogliptin 6.25 MG (as alogliptin benzoate 8.5 MG) Oral Tablet | SY | 22 | These highlights do not include all the information needed to use NESINA ® safely and effectively. See full prescribing information for NESINA. NESINA (alogliptin) tablets, for oral use Initial U.S. Approval: 2013 | 20250228 |
| a3768c7e-aa4c-44d3-bc53-43bb7346c0b0 | alogliptin 6.25 MG Oral Tablet | PSN | 22 | These highlights do not include all the information needed to use NESINA ® safely and effectively. See full prescribing information for NESINA. NESINA (alogliptin) tablets, for oral use Initial U.S. Approval: 2013 | 20250228 |
| a3768c7e-aa4c-44d3-bc53-43bb7346c0b0 | alogliptin 6.25 MG Oral Tablet | SCD | 22 | These highlights do not include all the information needed to use NESINA ® safely and effectively. See full prescribing information for NESINA. NESINA (alogliptin) tablets, for oral use Initial U.S. Approval: 2013 | 20250228 |
| b25f155a-1259-47c2-aa3b-7c1356e4c7f6 | alogliptin 6.25 MG Oral Tablet | SCD | 12 | These highlights do not include all the information needed to use ALOGLIPTIN TABLETS safely and effectively. See full prescribing information for ALOGLIPTIN TABLETS. Alogliptin Tablets, for oral use Initial U.S. Approval: 2013 | 20250411 |
| b25f155a-1259-47c2-aa3b-7c1356e4c7f6 | alogliptin 6.25 MG (as alogliptin benzoate 8.5 MG) Oral Tablet | SY | 12 | These highlights do not include all the information needed to use ALOGLIPTIN TABLETS safely and effectively. See full prescribing information for ALOGLIPTIN TABLETS. Alogliptin Tablets, for oral use Initial U.S. Approval: 2013 | 20250411 |
| b25f155a-1259-47c2-aa3b-7c1356e4c7f6 | alogliptin 6.25 MG Oral Tablet | PSN | 12 | These highlights do not include all the information needed to use ALOGLIPTIN TABLETS safely and effectively. See full prescribing information for ALOGLIPTIN TABLETS. Alogliptin Tablets, for oral use Initial U.S. Approval: 2013 | 20250411 |